Goodwin Investment Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Hold
249
0.6% 21
2026
Q1
$229K Hold
249
0.27% 26
2025
Q4
$268K Buy
+249
New +$238K 0.29% 22
2025
Q2
Sell
-649
Closed -$536K 33
2025
Q1
$536K Buy
649
+386
+147% +$321K 0.83% 14
2024
Q4
$203K Hold
263
0.11% 39
2024
Q3
$233K Buy
263
+13
+5% +$11.7K 0.1% 34
2024
Q2
$226K Hold
250
0.1% 33
2024
Q1
$194K Buy
+250
New +$178K 0.09% 34
2023
Q1
Sell
-249
Closed -$91.1K 156
2022
Q4
$91.1K Hold
249
0.06% 63
2022
Q3
$81K Buy
+249
New +$78.9K 0.06% 67
2022
Q2
Sell
-249
Closed -$71K 200
2022
Q1
$71K Buy
+249
New +$64.1K 0.05% 63

Other funds holding LLY

Goodwin Investment Advisory's LLY Position: Q2 2026 in Review

Goodwin Investment Advisory held its Eli Lilly (LLY) position steady in Q2 2026 at 249 shares worth $299K. The position accounts for 0.6% of the portfolio, ranked #21.

Goodwin Investment Advisory first reported a position in LLY in Q1 2022 and has held it in 11 quarters since. The position peaked at $536K in Q1 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Goodwin Investment Advisory held 249 shares of Eli Lilly worth $299K as of Q2 2026.
  • Goodwin Investment Advisory left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.6% of Goodwin Investment Advisory's portfolio in Q2 2026, its #21 holding.
  • Goodwin Investment Advisory first reported a position in Eli Lilly in Q1 2022 and has held it in 11 quarters since.
  • Goodwin Investment Advisory's Eli Lilly position peaked at $536K in Q1 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Goodwin Investment Advisory's 13F filing for Q2 2026, filed 19 Aug 2026.